Immunochina Pharmaceuticals logo

Immunochina Pharmaceuticals

ID: 5668195

Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.

1

Funding Rounds

$20.4m

Money raised

Recent Funding Rounds

Series C $20.4M Jan 2019

Overview

Immunochina provides cancer diagnosis and treatment services based on Chimeric Antigen Receptor T-cell immunotherapy.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

View Membership Plans Contact Sales

Access detailed insights on 71,000+ companies worldwide

Industries

Immunochina Pharmaceuticals is active in the following industries: